Drug Products
Before drug products are authorized for sale in Canada, Health Canada reviews them to assess their safety, efficacy and quality. Drug products include prescription and non-prescription pharmaceuticals, disinfectants and sanitizers with disinfectant claims.
What information can you find here?
This section contains links to reports and publications related to drug products.
- Announcements
- Fact Sheets
- Summary Basis of Decision documents are available, which outline the scientific and benefit/risk based decisions that factor into Health Canada's decision to grant market authorization for a drug or medical device.
- Good Guidance Practices
Drug Submission Performance Reports
The Drug Submission Review Performance Reports provide detailed metrics about the timeliness of pre-market drug review process against performance service standards. The annual report compares five consecutive fiscal years (April 1 - March 31), while the quarterly report compares five quarters. The reports are broken down by operational areas. The Therapeutic Product Directorate (TPD) was renamed to the Pharmaceutical Drugs Directorate (PDD). The PDD report summarises performance metrics for pharmaceuticals. The Biologics and Genetic Therapies Directorate (BGTD) was renamed to the Biologic and Radiopharmaceutical Drugs Directorate (BRDD). The BRDD report summarises performance metrics for biologics and radiopharmaceutical drugs. The Natural and Non-Prescription Health Products Directorate (NNHPD) report summarises performance metrics for non-prescription (over-the-counter) and disinfectant drugs. Within each report, statistics are provided by submission type and show the number received, the number in workload, the number of decisions and the number of approvals and time to approval.
Submissions Received are counts of submissions received during the year using the filing date. Workload is reported as the number of submissions "under active review" on a given day. "Backlog" is the proportion of the workload that is over target. "Approvals" are Notice of Compliances (NOC) issued or issuable; an issuable NOC arises when a submission NOC is placed "on hold" awaiting authorization to market, due to requirements in the Patented Medicines (Notice of Compliance) Regulations, or due to a conversion of status from prescription to Over the Counter.
Drug Submission Performance Reports are available by request only. Please see contact information below.
Annual Reports
PDD:
- To obtain a full electronic copy of the PDD Annual Drug Submission Performance report for Fiscal Year 2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Annual Drug Submission Performance report for Fiscal Year 2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Annual Drug Submission Performance report for Fiscal Year 2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Annual Drug Submission Performance report for Fiscal Year 2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Annual Drug Submission Performance report for Fiscal Year 2017-2018 please contact publications-publications@hc-sc.gc.ca.
- A revised version of the PDD Annual Drug Submission Performance report for Fiscal Year 2016-2017 is available. To obtain a full electronic copy please contact publications-publications@hc-sc.gc.ca.
BRDD:
- To obtain a full electronic copy of the BRDD Annual Drug Submission Performance report for Fiscal Year 2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Annual Drug Submission Performance report for Fiscal Year 2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Annual Drug Submission Performance report for Fiscal Year 2019-2020 please contact publications-publications@hc-sc.gc.ca.
- Note: The report was revised on September 1, 2020.
- To obtain a full electronic copy of the BRDD Annual Drug Submission Performance report for Fiscal Year 2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Annual Drug Submission Performance report for Fiscal Year 2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Annual Drug Submission Performance report for Fiscal Year 2016-2017 please contact publications-publications@hc-sc.gc.ca.
NNHPD:
- To obtain a full electronic copy of the NNHPD Annual Drug Submission Performance report for Fiscal Year 2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Annual Drug Submission Performance report for Fiscal Year 2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Annual Drug Submission Performance report for Fiscal Year 2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Annual Drug Submission Performance report for Fiscal Year 2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Annual Drug Submission Performance report for Fiscal Year 2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Annual Drug Submission Performance report for Fiscal Year 2016-2017 please contact publications-publications@hc-sc.gc.ca.
Quarterly Reports
PDD:
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q4-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q3-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q2-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q1-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q4-2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q3-2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for January - September 2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q3-2019-2020 please contact publications-publications@hc-sc.gc.ca
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q2-2019-2020 please contact publications-publications@hc-sc.gc.ca
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q1-2019-2020 please contact publications-publications@hc-sc.gc.ca
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q4-2018-2019 please contact publications-publications@hc-sc.gc.ca
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q3-2018-2019 please contact publications-publications@hc-sc.gc.ca
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q2-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q1-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q4-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q3-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q2-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q1-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q4-2016-2017 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q3-2016-2017 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the PDD Quarterly Drug Submission Performance report for Q2-2016-2017 please contact publications-publications@hc-sc.gc.ca
BRDD:
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q4-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q3-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q2-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q1-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q4-2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q3-2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for January - September 2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q3-2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q2-2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q1-2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q4-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q3-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q2-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q1-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q4-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q3-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q2-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q1-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q4-2016-2017 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q3-2016-2017 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the BRDD Quarterly Drug Submission Performance report for Q2-2016-2017 please contact publications-publications@hc-sc.gc.ca
NNHPD:
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q4-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q3-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q2-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q1-2021-2022 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q4-2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q3-2020-2021 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for January - September 2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q3-2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q2-2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q1-2019-2020 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q4-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q3-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q2-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q1-2018-2019 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q4-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q3-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q2-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q1-2017-2018 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q4-2016-2017 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q3-2016-2017 please contact publications-publications@hc-sc.gc.ca.
- To obtain a full electronic copy of the NNHPD Quarterly Drug Submission Performance report for Q2-2016-2017 please contact publications-publications@hc-sc.gc.ca.
Reports
- Statistical Report 2023/2024 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact publications-publications@hc-sc.gc.ca). [2024-08-13]
- Statistical Report 2022/2023 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact publications-publications@hc-sc.gc.ca). [2023-06-23]
- Statistical Report 2021/2022 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact publications-publications@hc-sc.gc.ca.) [2022-07-29]
- Statistical Report 2020/2021 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact publications-publications@hc-sc.gc.ca.) [2021-11-10]
- Statistical Report 2019/2020 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact publications-publications@hc-sc.gc.ca.) [2020-09-02]
- Statistical Report 2018/2019 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact publications-publications@hc-sc.gc.ca.) [2019-06-28]
- Stakeholder Workshop on a National Buprenorphine Program [2004-12-06]
Page details
- Date modified: